Picture of Metacrine logo

MTCR — Metacrine News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro Cap

Metacrine Inc expected to post a loss of 63  cents a share - Earnings Preview

* Metacrine Inc  MTCR.OQ   MTCR.O  is expected to show no
change
in quarterly revenue when it reports  results on March 16
(estimated). 
    * ​Refinitiv's mean analyst estimate for Metacrine Inc is
for a
loss of 63 cents per share. For the same quarter last year, the
company reported a loss of $1.15 per share.
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Metacrine
Inc is
$8.25​, above​ its last closing price of $0.47. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2021  -0.61       -0.61      -0.69     Missed  -13.1
 Jun. 30 2021  -0.61       -0.60      -0.59     Beat    2.1
 Mar. 31 2021  -0.49       -0.51      -0.57     Missed  -12.5​
 Dec. 31 2020  -0.36       -0.38      -1.15     Missed  -202.6
 ​​Sep.        -0.41       -0.41      -1.41     Missed  -243.9
 30 2020                                                
                                                        ​
 This summary was machine generated March 14 at 13:10 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Metacrine

See all news